These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 24696607)

  • 1. Biomarkers in inflammatory bowel diseases: current status and proteomics identification strategies.
    Bennike T; Birkelund S; Stensballe A; Andersen V
    World J Gastroenterol; 2014 Mar; 20(12):3231-44. PubMed ID: 24696607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low Mass Blood Peptides Discriminative of Inflammatory Bowel Disease (IBD) Severity: A Quantitative Proteomic Perspective.
    Wasinger VC; Yau Y; Duo X; Zeng M; Campbell B; Shin S; Luber R; Redmond D; Leong RW
    Mol Cell Proteomics; 2016 Jan; 15(1):256-65. PubMed ID: 26530476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Usefulness of Proteomics in Inflammatory Bowel Disease: A Comprehensive Review.
    Gisbert JP; Chaparro M
    J Crohns Colitis; 2019 Mar; 13(3):374-384. PubMed ID: 30307487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic insights on the metabolism in inflammatory bowel disease.
    Pisani LF; Moriggi M; Gelfi C; Vecchi M; Pastorelli L
    World J Gastroenterol; 2020 Feb; 26(7):696-705. PubMed ID: 32116417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of fecal biomarkers in individuals with inflammatory bowel disease.
    Edwards TS; Day AS
    Expert Rev Mol Diagn; 2024 Jun; 24(6):497-508. PubMed ID: 38995110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic Analysis Identifies Three Reliable Biomarkers of Intestinal Inflammation in the Stools of Patients With Inflammatory Bowel Disease.
    Vitali R; Palone F; Armuzzi A; Fulci V; Negroni A; Carissimi C; Cucchiara S; Stronati L
    J Crohns Colitis; 2023 Jan; 17(1):92-102. PubMed ID: 36040453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative proteomic approaches in biomarker discovery of inflammatory bowel disease.
    Han NY; Kim EH; Choi J; Lee H; Hahm KB
    J Dig Dis; 2012 Oct; 13(10):497-503. PubMed ID: 22988922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel serological biomarkers for inflammatory bowel disease using Escherichia coli proteome chip.
    Chen CS; Sullivan S; Anderson T; Tan AC; Alex PJ; Brant SR; Cuffari C; Bayless TM; Talor MV; Burek CL; Wang H; Li R; Datta LW; Wu Y; Winslow RL; Zhu H; Li X
    Mol Cell Proteomics; 2009 Aug; 8(8):1765-76. PubMed ID: 19357087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic analysis of ascending colon biopsies from a paediatric inflammatory bowel disease inception cohort identifies protein biomarkers that differentiate Crohn's disease from UC.
    Starr AE; Deeke SA; Ning Z; Chiang CK; Zhang X; Mottawea W; Singleton R; Benchimol EI; Wen M; Mack DR; Stintzi A; Figeys D
    Gut; 2017 Sep; 66(9):1573-1583. PubMed ID: 27216938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical Modulators of Tight Junctions (TJs): Occludin, Claudin-2 and Zonulin as Biomarkers of Intestinal Barrier Leakage in the Diagnosis and Assessment of Inflammatory Bowel Disease Progression.
    Górecka A; Jura-Półtorak A; Koźma EM; Szeremeta A; Olczyk K; Komosińska-Vassev K
    Molecules; 2024 Sep; 29(19):. PubMed ID: 39407507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel, objective, multivariate biomarkers composed of plasma amino acid profiles for the diagnosis and assessment of inflammatory bowel disease.
    Hisamatsu T; Okamoto S; Hashimoto M; Muramatsu T; Andou A; Uo M; Kitazume MT; Matsuoka K; Yajima T; Inoue N; Kanai T; Ogata H; Iwao Y; Yamakado M; Sakai R; Ono N; Ando T; Suzuki M; Hibi T
    PLoS One; 2012; 7(1):e31131. PubMed ID: 22303484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capturing the Biologic Onset of Inflammatory Bowel Diseases: Impact on Translational and Clinical Science.
    Sorrentino D; Nguyen VQ; Chitnavis MV
    Cells; 2019 Jun; 8(6):. PubMed ID: 31174359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis.
    Mortensen JH; Godskesen LE; Jensen MD; Van Haaften WT; Klinge LG; Olinga P; Dijkstra G; Kjeldsen J; Karsdal MA; Bay-Jensen AC; Krag A
    J Crohns Colitis; 2015 Oct; 9(10):863-72. PubMed ID: 26188349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease.
    Williams AD; Korolkova OY; Sakwe AM; Geiger TM; James SD; Muldoon RL; Herline AJ; Goodwin JS; Izban MG; Washington MK; Smoot DT; Ballard BR; Gazouli M; M'Koma AE
    PLoS One; 2017; 12(8):e0179710. PubMed ID: 28817680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Current State of Proteomics in Adult and Pediatric Inflammatory Bowel Diseases: A Systematic Search and Review.
    Fabian O; Bajer L; Drastich P; Harant K; Sticova E; Daskova N; Modos I; Tichanek F; Cahova M
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Throughput Identification of the Plasma Proteomic Signature of Inflammatory Bowel Disease.
    Di Narzo AF; Brodmerkel C; Telesco SE; Argmann C; Peters LA; Li K; Kidd B; Dudley J; Cho J; Schadt EE; Kasarskis A; Dobrin R; Hao K
    J Crohns Colitis; 2019 Mar; 13(4):462-471. PubMed ID: 30445421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before Diagnosis.
    Torres J; Petralia F; Sato T; Wang P; Telesco SE; Choung RS; Strauss R; Li XJ; Laird RM; Gutierrez RL; Porter CK; Plevy S; Princen F; Murray JA; Riddle MS; Colombel JF
    Gastroenterology; 2020 Jul; 159(1):96-104. PubMed ID: 32165208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.
    Yang Z; Clark N; Park KT
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):253-62.e2. PubMed ID: 23883663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
    Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
    PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingolipid Analysis Indicate Lactosylceramide as a Potential Biomarker of Inflammatory Bowel Disease in Children.
    Filimoniuk A; Blachnio-Zabielska A; Imierska M; Lebensztejn DM; Daniluk U
    Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32708181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.